Inscription Capital, LLC Gilead Sciences, Inc. Transaction History

Inscription Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $261,797 - $299,039	-4,397 Closed	0 $0
Q2 2022 Sep 20, 2022	BUY	$57.72 - $65.01 $253,794 - $285,848	4,397 New	4,397 $272,000
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $249,573 - $269,261	-3,687 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $234,013 - $255,693	3,687 New	3,687 $254,000

1,926

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Inscription Capital, LLC with notifications on news.